In 2021, Agilent completed the acquisition of Resolution Bioscience, a leader in the development and commercialization of NGS-based precision oncology solutions. Resolution Bioscience complemented and expanded Agilent’s capabilities in NGS-based cancer diagnostics and provided the company with innovative technology to further serve the needs of the fast-growing precision medicine market.

Northbrook, IL 60062 -- (SBWire) -- 09/14/2023 --NGS Sample Preparation Market displayed remarkable growth in terms of revenue. In 2022, the market was estimated to be valued at $1.9 billion, and it is anticipated to achieve a significant milestone by reaching $4.0 billion by 2028. This impressive growth trajectory is characterized by a robust compound annual growth rate (CAGR) of 13.4% from 2022 to 2028.

Several key factors are contributing to the dynamic expansion of this market. Notably, advancements in NGS platforms have played a pivotal role, pushing the boundaries of what is achievable in genomics research. Additionally, the declining cost of sequencing has democratized access to NGS technologies, making them more accessible to researchers and institutions. NGS is also gaining traction as a viable alternative to traditional PCR methods, further propelling its adoption across various scientific domains. Furthermore, the increased efficiency of genotyping and sample preparation protocols is streamlining workflows and driving market growth.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=69735098

Browse in-depth TOC on "NGS Sample Preparation Market"
299 - Tables
47 - Figures
301 – Pages

Key Market Players:

The market for NGS sample preparation is highly consolidated, with key players strategizing to capture the market. Prominent players in the NGS sample preparation market are Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), PerkinElmer Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Danaher (US), Becton, Dickinson and Company (US), Merck KGAA (Germany), QIAGEN (Germany), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Eurofins Scientific (Luxembourg), BGI (China), 10x Genomics (US), Sysmex Corporation (US), Psomagen (US), Zymo Research Corporation (US), Takara Bio Inc. (Japan), Novogene Co., Ltd. (China), New England Biolabs (US), Tecan Trading AG (US), Oxford Nanopore Technologies PLC (UK), PacBio (US), Medgenome (US), and Swift Biosciences Inc. (US).

NGS Sample Preparation Market Dynamics:

Drivers:

1. Constant innovations in NGS platforms
2. Increased availability of advanced NGS systems at low costs
3. Use of NGS as substitute for PCR
4. Greater efficiency of genotyping and preparation protocols

Restraints:

1. Presence of alternative technologies
2. Limited expertise and sequencing capabilities of individual laboratories

Opportunities:

1. Increasing collaborations and partnerships among key players

Challenges:

1. Ethical and privacy issues in health data

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=69735098

DNA segment accounted for the largest share of the NGS sample preparation market

Based on the sample type, the NGS sample preparation market is segmented into DNA and RNA. In 2022, the DNA segment accounted for the largest share of the NGS sample preparation market. Growth in this market segment can be attributed to the rising number of cancer cases and growing R&D investments for studying DNA samples.

DNA fragmentation & library preparation is the fastest-growing workflow segment of the NGS sample preparation market

Based on workflow, the NGS sample preparation market is segmented into DNA fragmentation & library preparation, target enrichment, and quality control. In 2022, the DNA fragmentation &library segment accounted for the fastest-growing share of the workflow segment of NGS sample preparation market. Market growth can largely be attributed to the availability of new products, and advancements in the NGS protocols.

Asia Pacific: The fastest-growing region in the NGS sample preparation market.

The Asia Pacific NGS sample preparation market is projected to grow at the highest CAGR during the forecast period, mainly due to the rising focus on R&D activities, increasing adoption of NGS for diagnostics, and technological development in NGS data analysis.

Recent Developments

- In 2021, Agilent completed the acquisition of Resolution Bioscience, a leader in the development and commercialization of NGS-based precision oncology solutions. Resolution Bioscience complemented and expanded Agilent's capabilities in NGS-based cancer diagnostics and provided the company with innovative technology to further serve the needs of the fast-growing precision medicine market.

- In 2020, Roche announced that it has entered into a 15-year, non-exclusive partnership with Illumina to broaden the adoption of distributable next-generation sequencing (NGS) based testing in oncology.

- In 2021, Thermo Fisher Scientific announced the acquisition of clinical research services provider PPD.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=69735098

NGS Sample Preparation Market Advantages:

- High Throughput: NGS sample preparation is able to process large numbers of samples quickly and efficiently, allowing for faster and more accurate data collection.

- Automation: Automation of the sample preparation process reduces the amount of time and labor required, resulting in cost savings.

- Flexibility: NGS sample preparation offers a variety of different protocols and methods, allowing researchers to customize their sample preparation according to the desired output.

- Cost Effectiveness: NGS sample preparation is cost effective compared to other methods, making it more attractive to both academic and commercial laboratories.

- Increased Accuracy: NGS sample preparation is known for its increased accuracy compared to traditional methods, resulting in more reliable and reproducible results.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.